PacWest Financial Management’s Gilead Sciences GILD Stock Holding History

PacWest Financial Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7.24M	Sell	10,115 -5,945	-37%	-$442K	0.43%	68
2016 Q3	$1.27M	Sell	16,060 -10	-0.1%	-$812	0.78%	61
2016 Q2	$1.34M	Buy	16,070 +520	+3%	+$46.1K	0.84%	58
2016 Q1	$1.43M	Buy	15,550 +105	+0.7%	+$9.47K	0.92%	53
2015 Q4	$1.56M	Buy	15,445 +930	+6%	+$96.8K	1.05%	45
2015 Q3	$1.43M	Buy	14,515 +995	+7%	+$111K	1.05%	48
2015 Q2	$1.58M	Buy	13,520 +5	+0%	+$546	1.11%	45
2015 Q1	$1.33M	Buy	13,515 +1,130	+9%	+$115K	0.94%	55
2014 Q4	$1.17M	Buy	+12,385	New	+$1.28M	0.83%	61

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PacWest Financial Management's GILD Position: Q4 2016 in Review

PacWest Financial Management reduced its Gilead Sciences (GILD) stake by 37% in Q4 2016, selling an estimated $442K and leaving 10,115 shares worth $7.24M. The position accounts for 0.43% of the portfolio, ranked #68.

PacWest Financial Management first reported a position in GILD in Q4 2014 and has held it in 9 quarters since. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

PacWest Financial Management held 10,115 shares of Gilead Sciences worth $7.24M as of Q4 2016.
PacWest Financial Management sold 5,945 Gilead Sciences shares in Q4 2016, an estimated $442K.
Gilead Sciences made up 0.43% of PacWest Financial Management's portfolio in Q4 2016, its #68 holding.
PacWest Financial Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 9 quarters since.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on PacWest Financial Management's 13F filing for Q4 2016, filed 10 Jan 2017.